Hectors, Stefanie J.
Bane, Octavia
Kennedy, Paul
Cuevas, Jordan
Thung, Swan
Fischman, Aaron
Friedman, Scott L.
Schiano, Thomas D.
Taouli, Bachir http://orcid.org/0000-0001-6409-1333
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK113272)
Article History
Received: 16 July 2020
Revised: 25 September 2020
Accepted: 10 November 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: The scientific guarantor of this publication is Bachir Taouli.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Twenty-five of the included patients have been previously reported in Hectors et al Splenic T1ρ as a noninvasive biomarker for portal hypertension. J Magn Reson Imaging. doi: 10.1002/jmri.27087.
: • prospective• observational• performed at one institution